Symptomless COVID infections found in almost half of US adults, CDC says
By
Alicia Lasek
Dec 05, 2022
Approximately 44% of US adults were “possibly asymptomatically infected,” between August 2021 and May 2022, blood serum evidence shows.
‘Confounded’ providers urge mandated COVID-19 testing for hospital workers, surveyors
By
James M. Berklan
Oct 01, 2020
Healthcare stakeholders who regularly come into contact with skilled nursing residents should be subject to COVID-19 testing mandates similar to those for nursing home employees, a prominent long-term...
Second J&J shot ‘significantly’ increases COVID-19 antibodies; firm heads toward approval process
By
Danielle Brown
Aug 26, 2021
A Johnson & Johnson COVID-19 booster could be made available to long-term care residents and healthcare providers, as well as the rest of the American public, after the company unveiled promising results...
Report: 1 in 5 will rebound after Paxlovid, but it still works
By
Kristen Fischer
Nov 14, 2023
One in five people who take nirmatrelvir/ritonavir (Paxlovid) get COVID-19 again after the drug clears them of it, according to a new study.
Unforeseen consequences pile up in race to find COVID-19 treatments
By
Alicia Lasek
Mar 25, 2020
The national attention gained by an experimental drug and two existing medications has led to unintended trouble for patients.
Federal Trade Commission must protect short-staffed providers from price gouging: AHCA
By
Danielle Brown
Kimberly Marselas
Oct 22, 2021
The nation’s largest nursing home association this week added its voice to calls for federal intervention in alleged price gouging by direct care staffing agencies amid labor shortages exacerbated by...
Merck to seek emergency use for COVID-19 antiviral pill that cuts severe outcomes by 50 percent
By
Alicia Lasek
Oct 04, 2021
Molnupiravir has reduced COVID-19 deaths and hospitalizations by half in a new clinical trial. An orally delivered drug could offer unprecedented treatment convenience, the drug’s developers say.
Profile: Ruth Katz, Prone to Make It Happen
By
John Hall
Apr 08, 2018
Ruth Katz, SVP Public Policy LeadingAge
Paxlovid cuts COVID hospitalization, which may leave older adults weakened
By
Alicia Lasek
Dec 02, 2022
The CDC reports that COVID patients treated with the antiviral Paxlovid have a 51% lower risk of hospitalization, while another study has tied acute-care stays to muscle loss and long COVID.
Future survey success hinges on audits of emergency preparedness plans: expert
By
Danielle Brown
Nov 16, 2020
It’s crucial for providers to be able to document and demonstrate their emergency preparedness and how they responded to the COVID-19 pandemic as survey activities resume across the country, according...